Hansen, Melissa V.
Novo Nordisk (Denmark)
2 papers on CoChatORCID 0000-0001-7116-2216
Most cited papers
- Verified
Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes: The randomised, head-to-head CONCLUDE trial
on behalf of the CONCLUDE Study Group, Philis-Tsimikas, A., Klonoff, D. C., Khunti, K., Bajaj, H. S., Leiter, L. A., Hansen, M. V., Troelsen, L. N., Ladelund, S., Heller, S., et al. (2020) · Diabetologia
Diabetes Management and ResearchDiabetes Treatment and Management
Cited by 73
- Verified
Lower rates of hypoglycaemia in older individuals with type 2 diabetes using insulin degludec versus insulin glargine u100: Results from switch 2
Heller, S. R., DeVries, J. H., Wysham, C., Hansen, C. T., Hansen, M. V., & Frier, B. M. (2019) · Diabetes, Obesity and Metabolism
Diabetes Management and ResearchDiabetes Treatment and Management
Cited by 18
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free